Registration Dossier

Administrative data

Endpoint:
water solubility
Type of information:
not specified
Adequacy of study:
weight of evidence
Reliability:
other: not applicable
Rationale for reliability incl. deficiencies:
other: no experimental test performed => study has to be aborted prior to start of experimental phase
Data waiving:
other justification
Justification for data waiving:
other:

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
2009
Report date:
2009

Materials and methods

Test guideline
Qualifier:
according to guideline
Guideline:
EU Method A.6 (Water Solubility)
GLP compliance:
yes (incl. QA statement)
Type of method:
column elution method

Test material

Constituent 1
Chemical structure
Reference substance name:
3,5-bis{1-[4-(propan-2-yl)phenyl]propan-2-yl}dihydro-1H-[1,3]oxazolo[3,4-c][1,3]oxazole
Cas Number:
1001164-15-3
Molecular formula:
C29 H41 N O2
IUPAC Name:
3,5-bis{1-[4-(propan-2-yl)phenyl]propan-2-yl}dihydro-1H-[1,3]oxazolo[3,4-c][1,3]oxazole
Constituent 2
Reference substance name:
TN]Sa 163[/TN][SPEC][/SPEC][AM]94%[/AM]
IUPAC Name:
TN]Sa 163[/TN][SPEC][/SPEC][AM]94%[/AM]

Results and discussion

Any other information on results incl. tables

The study has to be aborted prior to start of experimental phase

Applicant's summary and conclusion

Conclusions:
Interpretation of results (migrated information): other: Test has to be aborted
The study has to be aborted prior to start of experimental phase